Jane Street Group, LLC Inmune Bio, Inc. Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$10.53 - $14.01 $324,703 - $432,012	30,836 Added 71.49%	73,970 $869,000
Q4 2023 Feb 14, 2024	BUY	$6.6 - $11.52 $284,684 - $496,903	43,134 New	43,134 $485,000
Q1 2022 May 17, 2022	SELL	$6.42 - $11.39 $109,769 - $194,746	-17,098 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$9.97 - $20.38 $170,467 - $348,457	17,098 New	17,098 $175,000
Q2 2021 Aug 16, 2021	SELL	$9.29 - $19.33 $113,533 - $236,231	-12,221 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$11.61 - $26.85 $141,885 - $328,133	12,221 New	12,221 $145,000

4.66M

80K

41.8K

Ticker INMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,946,000
Market Cap $93.7M
Description
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.